Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results